Is this email not displaying correctly? View it in your browser.
 
Newswise - News for Journalists
Newswise Special Wire
Tuesday, November 1, 2016

Public edition | newswise.com

Newswise Cancer Research Wire for 01-Nov-2016
 

Cancer Research Wire

Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.



New Target Could Halt Growth, Spread of Ovarian Cancer

Researchers have identified a protein that helps ovarian cancer cells multiply and spread. By blocking it with a new antibody agent, they could slow the cancer’s growth and stop it from metastasizing....

– University of Michigan Health System

Cancer Research; CA046592

Embargo expired on 01-Nov-2016 at 00:05 ET


The Dark Side of ‘Junk’ DNA

Researchers at the University of North Carolina Lineberger Comprehensive Cancer Center report in the journal Cell Reports that certain short, repetitive sequences of DNA, or “junk,” play an important role in the development of Ewing sarcoma....

– University of North Carolina Health Care System

Cell Reports, Nov-2016

Embargo expired on 01-Nov-2016 at 12:00 ET


Could Targeting a Gene Linked to Microcephaly Lead to a Better Brain Cancer Treatment?

In a study in the journal Development, UNC Lineberger Comprehensive Cancer Center researchers report preclinical findings showing promise for targeting a gene linked to microcephaly in infants as a treatment for medulloblastoma. ...

– University of North Carolina Health Care System

Development, Nov-2016

Embargo expired on 01-Nov-2016 at 09:00 ET


New Survey Shows Obesity Ties Cancer as Top Health Threat, Bigger Than Heart Disease and Diabetes for Most Americans

Understanding of Risks of Obesity is Improving, But Major Misperceptions About Causes and Treatments Persist ...

– American Society for Metabolic and Bariatric Surgery (ASMBS)

Journal of Gastrointestinal Surgery

Embargo expired on 01-Nov-2016 at 00:00 ET


Beta-Cryptoxanthin, a Carotenoid, Inhibits Nicotine-Linked Lung Cancer Development in Mice

New study finds that beta-cryptoxanthin, a carotenoid primarily found in plants, reduces lung cancer development and invasiveness in mouse and cell models. The results support human epidemiological studies associating high beta-cryptoxanthin intake w...

– Tufts University


NUS Scientists Discover the “Switch” That Makes Breast Cancer Cells Aggressive

A study by Dr Alan Prem Kumar from the Cancer Science Institute of Singapore at the National University of Singapore (NUS) and NUS Yong Loo Lin School of Medicine, together with Professor Shazib Pervaiz and Associate Professor Marie-Veronique Clement...

– National University of Singapore

Antioxidants & Redox Signaling


Study Raises Concerns About Timely Follow-Up to Positive Mammogram for the Uninsured

In the journal Cancer Epidemiology, Biomarkers & Prevention, researchers report that uninsured women under age 65 who received their mammogram at community screening clinics in North Carolina also were less likely to get follow-up within a year of a ...

– University of North Carolina Health Care System

Cancer Epidemiology, Biomarkers & Prevention


Patient Safety Benefits When Hospitals Provide Feedback to Staff Who Report Errors

A St. Jude Children’s Research Hospital analysis suggests that to improve patient safety, hospitals should focus on providing feedback to staff about changes resulting from past staff reports of safety-related events....

– St. Jude Children's Research Hospital

Journal of Patient Safety, November 1


Samumed Selected for Seven Presentations in Five Therapeutic Areas at American College of Rheumatology 2016 Annual Meeting

Samumed, a leader in tissue regeneration, today announced it has been selected to feature seven presentations in five different therapeutic areas at the 2016 American College of Rheumatology (ACR) Annual Meeting from November 11–16 in Washington, D...

– Samumed

American College of Rheumatology (ACR) Annual Meeting


Announcing Finances 101: An Online Toolkit for Young Adults with Cancer

Young adult cancer survivors need help navigating health insurance options during open enrollment and beyond. This toolkit helps them understand the basics without becoming overwhelmed. ...

– The Samfund


Key Protein Implicated in Negative Side Effects of Senescence

Researchers at The Wistar Institute have identified a protein that plays a critical role in the expression of cytokines and chemokines, and that decreasing this protein suppresses the expression of these secreted factors. This suggests that there may...

– Wistar Institute

Journal of Cell Biology, Oct-2016

Embargo expired on 31-Oct-2016 at 09:00 ET


Silencing SIRT2, a Sirtuin Enzyme, Reduces Malignancy in Deadly Breast Cancer Subtype

Silencing SIRT2, a member of the sirtuin family of enzymes, reduces the invasiveness of basal-like breast cancer cells in culture and inhibits tumor growth in mice, according to new research led by scientists from Tufts University School of Medicine....

– Tufts University


Treatment Hope Would Leave Liver Cancer Cells in Limbo

New treatment leaves liver cancer cells in limbo...

– MRC Clinical Sciences Centre/Institute of Clinical Sciences (ICS) Faculty of Medicine, Imperial College London

Genes and Development, Oct-2016


Less Than Half of Cervical Cancer Patients Receive Standard-of-Care Treatment

University of Colorado Cancer Center study published in the journal Gynecologic Oncology shows that only 44 percent of patients in a large, national sample received all three components of standard-of-care treatment, most often lacking brachytherapy....

– University of Colorado Cancer Center

Gynecologic Oncology


UTHealth: Out-of-Pocket Costs, Not Race, Can Explain Breast Cancer Treatment Disparities

High out-of-pocket costs, rather than race or ethnicity, are responsible for disparities associated with adherence to adjuvant endocrine therapy, according to a new study from researchers at The University of Texas Health Science Center at Houston (U...

– University of Texas Health Science Center at Houston


ISPOR 19th Annual European Congress Examines New Approaches to Survival Modeling in Oncology

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held a workshop this afternoon on "New Approaches to Survival Modeling in Oncology" at the Society’s 19th Annual European Congress in Vienna, Austria. ...

– International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

ISPOR 19th Annual European Congress


Getting Survivorship Care Planning Off the Page and Into Practice

Jennifer Klemp, PhD, MPH, director of cancer survivorship and an associate professor at The University of Kansas Cancer Center, is interviewed by Oncology Nursing News. In this interview, Klemp offers insights on some of the critical issues that clin...

Expert Available

– University of Kansas Cancer Center


Pembrolizumab in HNSCC Only Scratches the Surface of Immunotherapy Potential

The recent approval of pembrolizumab (Keytruda) in recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) following progression on a platinum-based chemotherapy was a significant advancement for the disease. However, Barbara A. Burtnes...

– Yale Cancer Center


FDA Approves Keytruda for First-Line Treatment of PD-L1–Expressing Metastatic NSCLC

The FDA granted approval to pembrolizumab for the first-line treatment of patients with metastatic non–small cell lung cancer whose tumors express programmed death ligand-1 as determined by an FDA–approved test....

– Yale Cancer Center


Stability of Exhausted T Cells Limits Durability of Cancer Checkpoint Drugs

Reinvigorating exhausted T cells in mice using a PD-L1 blockade caused very few T memory cells to develop. After the blockade, re-invigorated T cells became re-exhausted if antigen from the virus remained high, and failed to become memory T cells whe...

– Perelman School of Medicine at the University of Pennsylvania

CA78831, AI105343, AI112521, AI082630, AI115712, AI117950, AI108545

Embargo expired on 27-Oct-2016 at 14:00 ET


Link Between Molecular Mechanisms in Prostate Cancer and Ewing's Sarcoma, An Alternative to Chemotherapy for People with Advanced Lung Cancer, Terminally Ill Cancer Patients Fare Poorly After Surgery, and MORE in the Cancer News Source

Click here to go directly to the Cancer News Source...

– Newswise


Promise of Better Targeted Treatments Now Possible in Children’s Brain Cancer

More than 4,000 children and teens are diagnosed with brain cancer each year and the disease kills more children than any other cancer. Writing this week in the journal Cell Reports, researchers at Huntsman Cancer Institute (HCI) at the University of...

– Huntsman Cancer Institute at the University of Utah

Cell Reports; CA042014


50-Year-Old Bacteria Could Be Alternative Treatment Option for Cancer

Salmonella has a unique characteristic that allows the bacteria to penetrate through cell barriers and replicate inside its host. Now, scientists at the Cancer Research Center and the University of Missouri have developed a non-toxic strain of Salmon...

– University of Missouri Health

PLOS One


Cancer Sequencing Results Differ Based on Genetic Background of Comparison Genome

University of Colorado Cancer Center study shows that comparing cancer cell sequencing results to published reference genomes may be less accurate than comparing to healthy cell from same organism....

– University of Colorado Cancer Center

BMC Genomics


Antibody Breaks Leukemia’s Hold, Providing New Therapeutic Approach

Acute myeloid leukemia (AML) is an aggressive cancer known for drug resistance and relapse. In an effort to uncover new treatment strategies, researchers at University of California San Diego School of Medicine and Moores Cancer Center discovered tha...

– University of California San Diego Health Sciences

Cancer Cell


Mayo Clinic Study Shows That Choice of Medical Center Impacts Life Expectancy of Multiple Myeloma Patients

ROCHESTER, Minn. – People diagnosed with multiple myeloma are more likely to live longer if they are treated at a medical center that sees many patients with this blood cancer. Mayo Clinic researchers published these findings today in the Journal o...

– Mayo Clinic

Embargo expired on 26-Oct-2016 at 16:00 ET


New Insight on Cytomegalovirus Infection, Breakthrough Therapy for Patients with Giant Cell Arteritis, Zika Infection May Affect Adult Brain Cells and More in the Cell Biology News Source

The Latest in Cell Biology News...

– Newswise


Researchers Slow Glioblastoma by Inhibiting Tumor’s PPARα Receptor

One of the most remarkable features of glioblastoma is the metabolic reprogramming of cancerous cells, resulting in uncontrolled cell proliferation, hypoxic conditions and angiogenesis. Metabolic reprogramming enables tumor cells with a faster way to...

– Sbarro Health Research Organization (SHRO)

Journal of Cellular Physiology


Back Pain Led to Kidney Cancer Diagnosis for Survivor Turned Advocate

Four years ago, Merlinda Chelette was a hardworking ER nurse who suffered from excruciating back pain. When it became too painful to bear, she initially sought chiropractic care, but the pain got worse....

– UT Southwestern Medical Center


5 Steps to a Better Breast Self-Exam

If your monthly breast self-exam happens in the shower — sporadically — and involves a quick once-over of your breasts, you may be missing some important elements of an effective exam. In truth, the best and most thorough breast self-exam you can...

– City of Hope


Daughter Diagnosed with Breast Cancer Carries on Father's Fight - and Wins

A sudden breast cancer diagnosis will shake even the hardiest soul. But when Linh Quan received her news in the Spring of 2012, it was like being doubly kicked when she was already down....

– City of Hope


Drug Targeting Tumor Metabolism Discovered by MD Anderson’s Institute for Applied Cancer Science Enters Clinical Trial

The University of Texas MD Anderson Cancer Center’s Institute for Applied Cancer Science (IACS) has initiated the first clinical study of a novel drug designed to starve cancer cells, IACS-10759....

– University of Texas M. D. Anderson Cancer Center


Grand Challenge Initiative to Create Center for Cancer Research

...

– North Dakota State University


Breakthrough Drug Extensively Evaluated by UCLA Scientist Approved as Alternative to Chemotherapy for People with Advanced Lung Cancer

Pembrolizumab, an immunotherapy drug that was extensively evaluated by UCLA cancer researcher Dr. Edward Garon, has been approved by the U.S. Food & Drug Administration as first-line treatment for non-small cell lung cancer (NSCLC). The first-line de...

– University of California, Los Angeles (UCLA), Health Sciences


IU Research Reveals Link Between Molecular Mechanisms in Prostate Cancer and Ewing's Sarcoma

Medical researchers at Indiana University Bloomington have found evidence for a link between prostate cancer, which affects millions of men aged 50 and older, and Ewing’s sarcoma, a rare form of cancer that affects children and young adults. The re...

– Indiana University

Cell Reports; RSG-13-215-01


Announcements


International Celebration Spotlights Breast Imaging Advances

On Tuesday, Nov. 8, more than 140 medical societies worldwide will mark the International Day of Radiology (IDoR), celebrating the thousands of lives saved by the many contributions of breast imagers and radiation oncologists....

– American College of Radiology (ACR)


Fred Hutch Launches First-of-Its-Kind Immunotherapy Clinic

Fred Hutchinson Cancer Research Center today announced the official opening of a first-of-its-kind clinic dedicated to providing innovative immunotherapies for cancer patients in clinical trials....

– Fred Hutchinson Cancer Research Center


UTHealth’s Maria E. Fernandez, Ph.D., Named Distinguished Alumna by Alma Mater

Maria E. Fernandez, Ph.D., professor and director of the Center for Health Promotion and Prevention Research at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health, recently received the Distinguished Alumni Aw...

– University of Texas Health Science Center at Houston


Toronto Police Service Supports Breastober with Pink Fundraising Campaign

The Princess Margaret Cancer Foundation is pleased to announce the Toronto Police Service has come on board to support breast cancer research at the Princess Margaret Cancer Centre. ...

– University Health Network (UHN)


Radiology Leadership Institute Voted Best Radiologist Training Program

The Radiology Leadership Institute® (RLI), which provides radiologists with high-quality training in leadership and professional development, has won the “Best Radiologist Training Program” award in the 2016 Auntminnie.com “Minnies.”...

– American College of Radiology (ACR)


How Does the Gut Microbiome Influence Breast Cancer?

Researchers from the University of Illinois at Chicago and the University of Chicago have received a three-year, $900,000 Defense Department grant to investigate how the gut microbiome – the trillions of bacteria, viruses and other bugs that make o...

– University of Illinois at Chicago


Roswell Park Gets FDA Approval for Clinical Study of Cuban Lung Cancer Vaccine, License for Joint U.S.–Cuba Commercial Partnership

Spurred by NYS Trade Mission to Cuba in 2015, Buffalo cancer center will conduct a clinical trial with CIMAvax-EGF, groundbreaking immunotherapy for lung cancer developed in Cuba — becoming the first American center to receive FDA authorization to ...

– Roswell Park Cancer Institute


Association of Pediatric Hematology/Oncology Nurses Announces Pamela S. Hinds as the Winner of the First Ever Dr. Nancy E. Kline Mentoring Award

Chicago (Oct. 20, 2016): The Association of Pediatric Hematology/Oncology Nurses (APHON) has awarded Dr. Pamela S. Hinds, PhD RN FAAN with the first ever Dr. Nancy E. Kline Mentoring Award. This award was presented to Hinds at the 40th Annual APHON ...

– Association of Pediatric Hematology/Oncology Nurses (APHON)


Ellen and Gary Davis Immune Monitoring Core Established at Weill Cornell Medicine

With the goal of advancing a powerful cancer treatment strategy that uses immune cells to fight the disease, benefactors Ellen and Gary Davis have generously made a $2 million gift to Weill Cornell Medicine to drive ongoing research in immunotherapy,...

– Cornell University


University of Minnesota Researchers Win Breast Cancer Challenge Award

The University of Minnesota is one of two grand prize winners in the National Cancer Institute’s Up for A Challenge (U4C) Breast Cancer Challenge Award that will help further the University’s innovative work in exploring genetic connections in br...

– University of Minnesota College of Science and Engineering


Expert Pitch


Expert: Are We Measuring Cancer Therapy Effectiveness in the Best Way?

– Oncolytics Biotech


Yale Expert to Speak on FDA Approval of Keytruda for NSCLC

– Yale Cancer Center


Yale Expert on Breakthrough Clinical Trial Available for Triple Negative Breast Cancer

– Yale Cancer Center


Yale Expert to Speak on Tomosynthesis for Breast Cancer Detection

– Yale Cancer Center

Tips

CUSTOMIZE YOUR FAVORITES WITH "MY READING LIST"

MY CHANNELS  |  SAVED ARTICLES  |  MY SOURCES  |  MY EXPERTS

MORE CHANNELS:
JOURNAL NEWS   |  TRENDS AND TOP STORIES   |  LOCAL NEWS  |  MEDICAL and SCIENTIFIC MEETINGS

Support
 Subscribe/Unsubscribe
 Edit My Preferences
 Comments/Suggestions
 Contact Us
 
Services
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application

More News from:

  Newswise

 University of California, Los Angeles (UCLA), Health Sciences

 UT Southwestern Medical Center

 University of Texas M. D. Anderson Cancer Center

 University of Michigan Health System

 University of California San Diego Health Sciences

 MRC Clinical Sciences Centre/Institute of Clinical Sciences (ICS) Faculty of Medicine, Imperial College London

 University of Minnesota College of Science and Engineering


Subscribe / Unsubscribe
Edit my preferences

© 2016 Newswise, Inc. All Rights Reserved.

215 E. 5th St. SW, Charlottesville VA 22903 | 434-296-9417

 Contact Us